阳光诺和公告称，公司作为原告起诉恒生制药拖欠研发费用案处于一审判决阶段。法院判决恒生制药向 公司支付拖欠研发费用合计215.10万元及相应逾期支付违约金，涉及4起诉讼。各案按不同基数和时间 计算违约金，部分案件受理费双方分担。公司已对恒生制药应收账款和合同资产全额计提坏账准备，该 诉讼对当期及期后利润无负面影响。截至公告日，案件尚处上诉期，最终执行情况不确定。 ...

作者：凯风 又一个历史性时刻来了。 12月18日，海南自贸港正式启动全岛封关运作，实施以"'一线'放开、'二线'管住、岛内自由"为特征的制度。 这是继1988年海南建省、设立经济特区，2009年获批国际旅游岛，2018年获批全岛自贸区后的又一大机遇。 大定位带来大发展，海南会否成为下一个香港？ 01 中国最大自贸港，为何是海南？ 作为世界最高水平的开放形态，自贸港历来是开放高地和经济高地，中国香港地区、新加坡、迪拜、鹿特丹为佼佼者。 作为后来者，海南自贸港虽起步不久，但覆盖全岛，面积8倍于迪拜、31倍于香港、46倍于新加坡，堪称中国乃至全球最大自贸港。 以海南为试验田，与改革开放初期以深圳为试验田，1990年代以浦东为试验田，具有类似背景。 值得一提的是，海南自贸港还是唯一的中国特色自由贸易港，肩负探路重任。 过去10多年来，从上海到广东再到江浙，自贸区层出不穷，为何最终海南拿下自贸港？ 区位很关键。作为我国第二大岛和最大经济特区，海南是相对独立的地理单元，具备成为改革开放试验田的独特优势。 全岛自贸港，能带来什么好处？ 封关不是封岛，而是打造特殊的"境内关外"海关监管区域，以"一线放开，二线管住"为特征。 ...

声明说，由于主要目标市场依然疲软，今年货物出口额预计约为570亿美元，较2024年下降5.5%。 从出口目的地看，今年以色列对亚洲出口持续增长，增幅预计达3.5%；对非洲、拉丁美洲和大洋 洲出口温和增长；对欧盟国家出口下降约11%；对美国出口下降约4%。（完） 新华社耶路撒冷12月17日电（记者王卓伦 冯国芮）以色列经济产业部16日发表声明说，该国2025 年出口额预计将达到1600亿美元，较2024年增长3%，接近2022年创下的最高纪录1650亿美元。 根据声明，出口增长主要由软件、研发等高科技服务行业带动，凸显该行业对经济稳定的贡献。今 年服务出口额预计增长9%，达1010亿美元，占出口总额的52%。 ...

声明表示，出口增长反映了以色列经济的韧性，以及在经历了多线作战的"战争状态"后，经济仍能复苏 和发展的能力。出口增长还反映了对人力资本的投资以及对新市场的拓展，这些都为以色列经济的持续 增长奠定了基础。 （文章来源：新华财经） 同时，声明说，由于主要目标市场依然疲软，预计商品出口将从2024年的603亿美元下降5.5%至约570 亿美元。 声明说，2025年以色列对亚洲的出口持续增长，增幅达3.5%，而对非洲、拉丁美洲和大洋洲的出口则 呈现温和增长。对欧盟国家的出口下降约11%，对美国的出口下降约4%。 新华财经耶路撒冷12月16日电（记者王卓伦冯国芮）以色列经济产业部16日发表声明说，预计2025年该 国出口额达到约1600亿美元，比2024年增长3%，接近2022年创下的1650亿美元的纪录。 根据声明，服务出口占出口总额的52%，预计将增长9%，达到1010亿美元，高于2024年的927亿美元。 增长主要由软件、研发等高科技服务带动，凸显了这一行业对经济稳定的贡献。 ...

Core Points - The article discusses the calculation and categorization of research and development (R&D) expenses for tax deduction purposes, emphasizing the importance of accurate accounting for various types of costs associated with R&D activities [10][12][14]. Group 1: Types of R&D Expenses - The article identifies five core types of expenses related to R&D, which include personnel costs, direct input costs, depreciation expenses, intangible asset amortization, and design testing fees [3][6][7][12]. - Other related expenses include costs for technical literature, expert consultations, and travel expenses directly associated with R&D activities [8][12]. Group 2: Calculation of Additional Deductions - A hypothetical example illustrates how a technology company can calculate its R&D expenses and the additional deductions available under the policy, using a 100% additional deduction rate [10][13]. - The total R&D expenses are calculated by summing the five core expenses and applying a formula to determine the limit for other related expenses, which is set at 10% of the total core expenses [13]. Group 3: Accounting Requirements - Companies are required to maintain separate accounting for R&D expenses and production costs, ensuring accurate allocation of shared resources [14]. - For collaborative R&D projects, each party must account for their respective expenses according to the project plan and agreements [15]. Group 4: Documentation Requirements - The article outlines a list of documentation that companies must retain for R&D projects, including project plans, personnel lists, and expense allocation records [18][17].

Core Viewpoint - Hefei Chenliang Recycling Resources Co., Ltd. has been established with a registered capital of 1 million RMB, focusing on various recycling and resource utilization services [1] Company Summary - The legal representative of the company is Chen Liang [1] - The registered capital of the company is 1 million RMB [1] - The business scope includes general business projects such as recycling resource sales, processing, and recovery (excluding production waste metals) [1] - The company also engages in technology consulting for resource recycling, research and development for resource regeneration technology, and harmless utilization of agricultural and forestry waste [1] - Additional activities include processing of metal and non-metal waste materials, sales of environmental protection equipment, metal materials, and electronic components [1]

Group 1 - The major shareholder and director, Cao Xuming, plans to reduce his stake in Beijing Jingwei Hengrun Technology Co., Ltd. by up to 1,000,000 shares, which represents a maximum of 0.8336% of the total shares outstanding [2][3] - Cao Xuming currently holds 13.8 million shares, accounting for 11.51% of the total shares of Jingwei Hengrun [2] - The reduction will occur through centralized bidding and block trading methods, with a maximum of 200,000 shares through centralized bidding and 900,000 shares through block trading [3] Group 2 - The reduction period is set from October 15, 2025, to January 14, 2026 [3] - The reason for the share reduction is personal funding needs [3] - Jingwei Hengrun's main business involves providing electronic products, R&D services, and high-level intelligent driving solutions for global automotive and unmanned transportation sectors [3] Group 3 - For the first half of 2025, Jingwei Hengrun reported revenue of 2.908 billion yuan, representing a year-on-year increase of 43.48% [3] - The company recorded a net profit attributable to shareholders of -86.9644 million yuan, which is a year-on-year increase of 73.91% [3]

Group 1 - The core point of the announcement is the approval of the expected daily related transactions for the year 2025 by the company's supervisory board [1] - The related transactions involve the sale of pharmaceuticals and provision of production and research services to a related party, Hunan Hengchang Pharmaceutical Group Co., Ltd., by the company and its subsidiaries [1] - The transaction prices are based on market prices for similar businesses and are determined through friendly negotiations, ensuring fairness and reasonableness without adversely affecting the company's operations or harming the interests of minority shareholders [1] Group 2 - The supervisory board meeting was conducted in accordance with the Company Law and the company's articles of association, with all three participating supervisors voting in favor of the proposal [1] - The resolution received unanimous support with 3 votes in favor, 0 votes against, and 0 abstentions [1]

Group 1 - The core viewpoint is that Kanglong Chemical's business has been minimally affected by the recent U.S. tariffs, as their primary focus is on providing R&D services, with a small proportion of their business related to commercial goods exports [2] - The company has not received any feedback from clients or partners indicating that tariff issues have impacted their business collaborations [2] - Kanglong Chemical is closely monitoring macroeconomic uncertainties and related policy developments, while also advising investors to be aware of investment risks in the context of geopolitical factors [2]

Group 1 - The core viewpoint of the article highlights the current trends in domestic investment and financing activities, indicating a decrease in the number of financing events compared to the previous week [5][6]. - A total of 88 financing events were disclosed in the domestic primary market this week, a decrease of 27 events from the previous week, with a total financing scale of 2.503 billion RMB [5][6]. - The average financing amount per event is approximately 83 million RMB [6]. Group 2 - The most active sectors in terms of financing events this week are intelligent manufacturing, artificial intelligence, and healthcare, with 17, 14, and 8 events respectively [8]. - The highest financing scale among disclosed amounts is in the enterprise services sector, totaling approximately 720 million RMB, with significant funding for the AI infrastructure company "Silicon-based Flow" [8]. - The automotive transportation sector follows with a disclosed financing total of 420 million RMB, highlighted by the A-round financing of "East China Test Field" [8][9]. Group 3 - The regional distribution of disclosed financing events is primarily concentrated in Jiangsu, Shanghai, and Guangdong, with 17, 14, and 14 events respectively [12]. - Jiangsu reported a total financing of 200 million RMB from 5 disclosed events, while Shanghai had 635 million RMB from 6 events [15]. - The early-stage financing events dominate with 68 occurrences, while growth-stage and late-stage events account for 16 and 4 respectively [16]. Group 4 - This week, 7 companies were monitored for IPOs, with the highest market value being "Insta360" at 65.243 billion RMB [27]. - Most of the listed companies had prior investments from VC/PE or CVC, indicating a strong backing from investment firms [27]. - The article details the historical investors for each IPO, showcasing a diverse range of investment firms involved [28]. Group 5 - There were 11 disclosed completed M&A events this week, consistent with the previous week, spanning traditional industries, intelligent manufacturing, and healthcare [30][31]. - A notable transaction includes the acquisition of "China Ocean Shipping Passenger Transport" by Haixia Co. for 2.515 billion RMB [30]. - Other M&A activities include various companies in the intelligent manufacturing sector, with specific financial details provided for each transaction [33].